Risky Business

Posted by Geoff Davis at 04PM on 07/06/07 | Categories: NIH Crisis | 2 comments

The Chronicle reports that the National Science Board (the overseers of the NSF) are urging the NSF to fund riskier projects with the potential for big breakthroughs rather than safer, more incremental projects. (Here's the NSB report)

Taking more risks is likely to be a good thing for NSF. Consider the financial analog: it's like holding nothing but T-bills in your portfolio. Adding stocks (a riskier asset) to the mix in the right way can dramatically increase returns without greatly increasing risk.

I hope the goal of increased risk-taking on "transformative" research finds its way into the NIH, because if anything, the NIH is even more risk-averse than NSF. How much more can you do to avoid risk than the NIH's policy of (a) requiring in essence that people demonstrate that their projects will work before funding them (requiring "preliminary data") and (b) placing heavy emphasis on an established track record? These two policies are particularly hard on young people, who research suggests are more likely to come up with creative new ideas: because they are young, they don't have much of a track record, and and without an existing lab and funding in place, it's quite difficult to generate preliminary data. The result: less and less funding for young researchers.

The NIH is undergoing an examination of its own grantmaking processes as well in the wake of plummeting rates of grant success. Perhaps the National Science Board's report will shape their thinking?